Providence Swedish Cancer Institute Research

Sharing #Cancer #Research news updates from Providence Swedish Cancer Institute.

Tweets do not constitute medical advice

[The Lancet Oncology @TheLancetOncol]

Tarlatamab in combination with a PD-L1 inhibitor as first-line maintenance therapy after chemo-immunotherapy in patients with extensive-stage #SCLC (DeLLphi-303): a multicentre, phase 1b study

Presented today @IASLC #WCLC2025, 5 pm CEST

https://t.co/pGzVM7xha3

@ProvSwedCancRes

[Providence Swedish Cancer Institute Research @ProvSwedCancRes]

@DrKellyPaulson of @ProvSwedish presents international DeLLPhi-303 Ph1b trial at World Congress Lung Cancer in Barcelona on behalf of all centers: Overall Survival 25 months from start of ES-SCLC maintenance, compared to 10-15 mo in prior studies https://t.co/2qx9hQJtdA #WCLC25

[Providence Swedish Cancer Institute Research @ProvSwedCancRes]

Dr. Swathi Namburi @ProvSwedCancRes coauthors a clinical trial in @JCO_ASCO of new #bispecific antibody for #myeloma #immunotherapy https://t.co/8iltGTYsQC

[Providence Swedish Cancer Institute Research @ProvSwedCancRes]

Dr. Dubard-Gault cancer geneticist and preventionist @ProvSwedCancRes @ProvSwedish presents a rare cancer syndrome due to a newly described variant in JCO Precision Oncology: https://t.co/ww9wC4de9F

[Providence Swedish Cancer Institute Research @ProvSwedCancRes]

Dr. Aliea Herbert studies #cancerrehab in improving #survivorship after #HSCT with colleagues @EmoryUniversity @MayoClinic @MDAndersonNews https://t.co/i6I9ARsox5

[Providence Swedish Cancer Institute Research @ProvSwedCancRes]

Dr. Krish Patel @KrishPatelMD works with docs @WUSTLmed and @OHSUKnight to make #carT therapy for #lymphoma more patient friendly and cost-effective through #outpatient delivery https://t.co/BD4LIRIUx7

[Providence Swedish Cancer Institute Research @ProvSwedCancRes]

Dr. Devarakonda @ProvSwedCancRes participates in a study of new #targetedtherapy for #lungcancer #nsclc https://t.co/9wPb5kVMUO 🫁

[Providence Swedish @ProvSwedish]

Struggling to juggle your daily tasks while keeping your energy levels up? It's time to focus on energy conservation for a better quality of life! Sonja Braasch, OTR/L, senior occupational therapist, shares how you can save #energy for the things you love and need to do. 💪💡

[Providence NW WA @ProvidenceNW]

Please join us in welcoming our incoming class of physician #residents. Our residency program is known for its innovative learning environments, delivering on the Providence Mission and training our future physicians.

#ProvidenceSwedish #ProvidenceSwedishEverett #WSU

[OncLive.com @OncLive]

Navigating Neoadjuvant vs Adjuvant Immunotherapy Approaches in NSCLC Requires Further Elucidation
@ProvSwedCancRes #lcsm #oncology #MedTwitter
https://t.co/1nnQsh9GyB

[OncLive.com @OncLive]

Sid Devarakonda, MD, expands on the significance of OS data when evaluating a treatment for efficacy in NSCLC and noted the potential value of additional end points including pCR and EFS. @ProvSwedCancRes #lcsm #oncology #MedTwitter https://t.co/Q03zqRsBYW

[Binaytara @binaytara]

Amazing Thoracic Oncology session with Dr. Diane Tseng (@UWMedicine/@fredhutch), @AngelQinMD (@umichmedicine), & Dr. Siddhartha Devarakonda (@ProvSwedish) here at #BestofASCO24 📍Seattle!

[Providence Swedish Cancer Institute Research @ProvSwedCancRes]

Sunshine Gray presents on nursing experience with #tarlatamab at the oncology nursing society congress. So glad for the critical efforts of our RNs on our research team and the recent FDA approval of this #bispecific for #smallcelllungcancer https://t.co/6u9lADP3Ma

[Providence Swedish Cancer Institute Research @ProvSwedCancRes]

Dr. Krish Patel contributes to national guidelines on bispecific antibodies which are available at @ProvSwedish in both #clinicaltrials and as #standardofcare @ProvSwedCancRes https://t.co/O3i7lUe6GI

[Providence Swedish Cancer Institute Research @ProvSwedCancRes]

@ProvSwedCancRes researchers study rising incidence of #angiosarcoma in the United States in collaboration with @DanaFarber @ClevelandClinic @DukeU @fredhutch and others. @JAMANetworkOpen https://t.co/JkaBvYZ2IQ

[Providence Swedish Cancer Institute Research @ProvSwedCancRes]

Using AI deep learning to help understand cancer risk over time: no impact on vitamin D supplements on breast cancer risk using radiographic measures #swog https://t.co/KZNko4nfBI

[Providence Swedish Cancer Institute Research @ProvSwedCancRes]

Dr. Jed Gorden also publishes on reducing health disparities in #lungcancer https://t.co/llLlSXoKMm

[Providence Swedish Cancer Institute Research @ProvSwedCancRes]

Dr Jed Gorden @ProvSwedCancRes publishes on increasing access to #screening for #lungcancer in @accpchest https://t.co/aQKy75gq3z #prevention 🩻🫁

[Providence Swedish Cancer Institute Research @ProvSwedCancRes]

Dr. Charles Cobbs @ProvSwedCancRes publishes on overcoming treatment escape in glioblastoma: https://t.co/pwiZSh0YYN

[Providence Swedish Cancer Institute Research @ProvSwedCancRes]

Dr. Fengting Yan @ProvSwedish publishes in @NatureMedicine on a novel KAT6 inhibitor for advanced #breastcancer https://t.co/kwLwEIj9h4 👏👏